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ABSTRACT 
Bronchial asthma (BA) often develops in children with 
atopic dermatitis (AD). To clarify the usefulness of AD 
in infants as a predictor for the later development of 
BA, we examined the prevalence of and the risk factors 
for the later development of BA in infants with AD in 
four prefectures in Japan. We registered 157 infants 
with AD (100 boys and 57 girls) for the study and 151 
infants (95 boys and 56 girls) were successfully 
followed up for a mean duration of 1 year. Atopic 
dermatitis was cured and improved in 23 and 70% of 
the patients, respectively, during the follow-up period. 
Boys developed mite allergy more frequently than did 
girls during the follow-up period (P<0.05). Twelve 
boys and two girls were diagnosed as having BA
during the period, without any correlation with the 
outcome of the AD, and 12 boys developed wheezing 
but were not diagnosed as having BA by a physician. 
Male sex, a positive family history of BA, but not that of 
AD, and the appearance of mite-specific IgE during 
the follow-up period were identified as significant risk 
factors for the development of BA. The combination of 
a positive family history of BA and mite-specific IgE
and the same combination in the boys had high 
specificity (55 and 56%, respectively) and sensitivity 
(60 and 50%, respectively) as risk factors. The data 
suggest the involvement of genetic factors in the early 
development of BA in young children with AD and 
indicate that AD in infants and young children with 
these risk factors is a useful predictor for the 
development of BA within a short period. 
Key words: atopic dermatitis, bronchial asthma, 
children, prediction, prevalence.
INTRODUCTION 
It is well known that the prevalence of atopic diseases, 
such as atopic dermatitis (AD) and bronchial asthma (BA) 
has been increasing in many countries.1-3 The develop-
ment of atopic diseases is probably regulated by both 
genetic and environmental factors and the recent 
increase in the prevalence may be more dependent on 
environmental factors than on genetic factors, as genetic 
factors would not change in such a short period of time.
 The recent increase in the prevalence of atopic 
diseases emphasizes the importance of early prediction 
and prevention of the development of these diseases. 
High levels of total immunoglobulin (Ig) E and soluble 
CD23 in cord blood may or may not be useful for the 
prediction of the later development of atopic diseases*10 
However, the accuracy of the prediction of the later 
development of atopic diseases by cord blood IgE and
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soluble CD23 may be decreasing9 because it is probable 
that the cord blood levels of IgE and soluble CD23 are 
more influenced by genetic factors than by environmental 
factors. 
 It has been shown that AD usually develops prior to BA 
in children.11-18 We have demonstrated in a previous 
study that AD appears by 1 year of age in 72% of 
pediatric patients in Japan, whereas BA develops mainly 
in children at 2-4 years of age and that approximately 
50% of children with BA developed AD before the onset 
of BA.19 These results suggest that the appearance of AD 
in infants could be a useful predictor of the later 
development of BA if the risk factors were clarified for the 
later development of BA in patients with AD.
In the present study we registered infants with AD in
four prefectures in Japan and examined the prevalence of
and risk factors for the later development of BA among
them. The registered infants had not developed BA at or 
before the time of registration and had not yet reached
the common age of onset of BA among Japanese 
children. We present here the data for the 1 year follow-
up study and discuss the involvement of genetic factors in 




We registered 157 infants with AD (100 boys and 57 
girls; Table 1) who had visited pediatric out-patient clinics 
of Kyoto, Gunma and Gifu University Hospitals and of 
their related hospitals in Kyoto, Hyogo, Gunma and Gifu 
Prefectures between August 1994 and March 1995.
Informed consent for further examination was obtained 
from their parents or guardians. Patients without a past 
history of BA or wheezing were chosen. The patients were 
followed up for a mean duration of 1 year (range: 8-15 
months) and the outcome of the AD, development of BA 
and changes in immunological and other parameters 
were examined. When the patient did not visit the hospital 
for re-examination during the follow-up period, we
Table 1. Patients registered and re-examined
queried their parents by letter as to the outcome of the AD 
and the development of BA. Among the 157 children 
registered, data were available for 151 children (95% of 
boys and 98% of girls), either from re-examination or 
from responses to our letters. 
Diagnostic criteria for AD and bronchial 
asthma 
Atopic dermatitis was defined as a pruritic, chronic or 
chronically relapsing dermatitis with typical features and 
distribution20,21 diagnosed by a physician and the
diagnosis was confirmed by repeated examination. Bron-
chial asthma was defined as repeated episodes of 
reversible bronchial obstruction diagnosed by a 
physician. Patients who had wheezing with or without 
common cold-like symptoms but were not diagnosed as 
having BA by a physician were also evaluated. 
Parameters 
Serum total IgE levels and radioallergosorbent test (BAST) 
scores of IgE against mites (D1), egg white (F1), cows' 
milk (F2), wheat (F4), rice (F9) and soy bean (F14) were
examined using the CAP RAST FEIA system (Pharmacia 
Upiohn Diagnostics, Tokyo3 Japan).22 For several 
samples, the LUMIWARD,23 AlaSTAT24 or MAST25 system 
were used. These examinations were performed at the 
time of registration, during follow-up and at the end of 
the follow-up period in as many patients as possible. A 
BAST score at or more than 1 was defined as positive 
because the patients were infants and young children. 
The amily histories of BA and AD among first- and 
second-degree relatives were documented with 
interviews of the parents. The clinical course of AD was 
also examined.
Statistical methods 
Data were analyzed by the X2 test, Fisher's exact 
probability test and the Mann-Whitney U-test unless 
otherwise stated. Mean values are expressed as the
mean±SD.
RESULTS 
Characteristics of patients with AD 
Among the 151 patients followed up, 85% had specific 
IgE against at least one of the five major food allergens 
(egg white, cows' milk, wheat, rice and soy beans) and 
11% had IgE against mites (D1) at the time of registration
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(Table 2). Among the food allergens, egg white was the 
most common allergen, followed by cows' milk. 
Approximately 87% of patients with specific IgE against 
foods other than egg white also had specific IgE against 
egg white. There was no significant difference in the 
proportion of food allergy and mite allergy between boys 
and girls at registration, but boys had IgE against mites 
more frequently than did girls at re-examination (Table 3 
and data not shown).
 A family history of AD and BA was seen among the first-
and second-degree relatives of 33 and 22% of children, 
respectively (Table 4). There was no significant difference 
in the proportions of the family history between boys and 
girls (data not shown). 
  Keeping the skin clean was recommended to patients 
and they were treated with topical ointments with or 
without oral anti-allergy medication. Elimination of 
responsible foods was recommended for 92% of 
patients; for 98% of patients with positive IgE against 
foods and for 73% of patients without positive IgE against
T ble 2. Specific IgE in patients with atopic dermatitis at 
registration
A BAST score at 1 or higher was considered positive.
Table 3. Relationship between sex and mite allergy
Table 4. Risk factors for bronchial asthma (BA)
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foods it was recommended that the responsible foods 
and egg white, respectively, be eliminated from the diet. 
In breast-fed children, food elimination from the mother's 
diet was also recommended. The mean age at the start of
food elimination was 4.0±2.0 months and there was no
significant difference in the mean ages at the start of food 
elimination between patients who later developed BA
(3.9±2.1months) and patients who did not develop
BA (4.0±2.0 months). Although the compliance with
food elimination was not totally clear, the parents of 
88% of patients for whom food elimination was 
recommended continued food elimination during the 
follow-up period.
Outcome of AD and the development of BA 
During the follow-up period, AD was cured and 
improved in 23 and 70% of the patients, respectively. 
Only 5 and 3% of patients showed unchanged and 
increased severity of dermatitis, respectively. The effect of 
food elimination on the outcome of AD could not be 
clarified, in part because for almost all patients with IgE 
against foods it was advised that the foods be eliminated 
and in part because the compliance with food elimination 
in each patient was not clear. 
 Bronchial asthma was diagnosed in 14 patients (12 
boys and two girls; eight patients at 1 year of age and six 
patients at 2 years of age) during the follow-up period
Table 5. Relationship between food allerqy and mite allergy
  The presence or absence of mite allergy was determined by positive 
IgE against mites at re-examination.
(Table 4). In addition, nine and three boys developed 
wh ezing with and without common cold-like symptoms, 
r spectively, although none of them was diagnosed as 
h ving BA by a physician. 
Risk factors for BA in children with AD 
For identification of the risk factors for the development of 
BA, patients were divided into BA(+) and BA(-) groups. 
The BA(+) group consisted of 14 patients who were 
diagnosed with BA, while the BA(-) group of 125 patients 
who had neither BA nor wheezing. The 12 patients with
Table 7. Specificity and sensitivity of risk factors for the 
prediction of the later development of bronchial asthma
Specificity was calculated as (no. bronchial asthma patients with the
risk factor/no. patients with the risk factor)×100. Sensitivity was
calculated as (no. bronchial asthma patients with the risk factor/no.
bronchial asthma patients)×100.
Table 6. Major risk factors for bronchial asthma
  Data for patients who had developed wheezing but were not diagnosed as having bronchial asthma by a physician were excluded from this 
analysis.
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wheezing were not included in this analysis because their 
BA status was obscure. 
 There was no difference between BA(+) and BA(-) 
groups in the mean age at the time of registration
(5.1±2.8 and 5.4±2.6 months, respectively) and at the
time of re-examination (1.4±0.5 and 1.2±0.4 years,
respectively). 
 The mean level of total serum IgE increased during the
follow-up period (264±1283 and 669±2750IU/mL at
registration and re-examination, respectively; P<
0.0001 by Wilcoxon signed-ranks test). There was no 
significant difference in this level between the BA(+) and
BA(-) groups at registration (264±422 and 216±1146
IU/mL, respectively). The BA(+) group showed a higher 
mean serum IgE level than did the BA(-) group at re-
examination (1995±1868 and 425±1997IU/mL,
respectively), but the difference was not significant. 
 The proportion of children with mite-specific IgE 
increased during the follow-up period (11 and 37% at 
registration and at re-examination, respectively). There 
was no significant difference between the BA(+) and 
BA(-) groups in the mean BAST score for mite-specific IgE
at registration (0.8±1.5 and 0.2±0.6, respectively), but
the BA(+) group showed a significantly higher score than
did the BA(-) group at re-examination (2.6±2.0 and
0.7±1.3, respectively; P<0.01). The prevalence of BA
was significantly higher in patients with mite-specific IgE 
(Table 4). 
 With regard to the relationship between food allergy 
and mite allergy, all patients with IgE against mites at 
registration had IgE against foods and 94% of patients 
who showed positive IgE against mites during the follow-
up period had IgE against food. Patients with IgE against 
foods developed IgE against mites during the follow-up 
period more frequently than did those patients without 
IgE against foods, but the difference was not significant 
(Table 5). Patients with IgE against foods developed BA 
more frequently than did patients without IgE against 
foods (8.5 and 5.3%, respectively), but the difference was 
not significant.
 A positive family history of BA and male sex were also 
identified as risk factors for the development of BA, 
whereas the clinical course of AD, IgE antibody against 
foods and food elimination were not significant risk 
factors (Tables 4, 6). Among the risk factors, the 
combination of a family history of BA and mite-specific 
IgE, especially for male patients, had somewhat high 
specificity and sensitivity (Table 7). These factors were 
revealed as useful predictors of the later development of
BA in children with AD. When the 12 patients with 
wheezing were included in the BA(+) group, the use-
fulness of the risk factors was not changed significantly. 
DISCUSSION 
In the present study we examined data for infants with AD 
with a mean follow-up period of 1 year to determine the 
risk factors for the development of BA within the short-
term period. A 1 year follow-up period is apparently too 
short to determine the accurate prevalence of and risk 
factors for the development of BA in children with AD. 
There have been several reports citing a higher 
prevalence of BA in AD children.11,15,17 However, the 
present study revealed several interesting findings in 
relation to a genetic tendency in allergic march26,27 in 
atopic children. 
 The AD in infants and young children is relatively easily 
cured. This is in good agreement with our previous data
and other reported data.13,19,28,29 The effects of food 
elimi ation on the long-term clinical course of AD and on 
the subsequent respiratory atopy are controversial. 14,30-32 
The effects may vary depending on the start of and 
complia ce with food elimination. In the present study we 
could not clarify the effect of food elimination on the 
clinical course of AD and on the later development of BA 
because there was no control group in which the respon-
sible foods were not eliminated. We previously found that 
the outcome of AD in children was relatively good even 
wi hout any therapy, including food elimination.19
 Although 63% of patients registered and re-examined 
in the present study were boys, the percentage of boys in 
the BA(+) group was 86%. In the general population of 
Japanese children with BA, the percentage of males is 
55-60% (M Mayumi et al., unpubl. obs., 1992). It is 
i teres ing to consider that boys obtained mite allergy 
more frequently than did girls during the follow-up 
period. As the mite is the most common allergen in BA, it 
is possible that boys, at least male infants with AD, have a 
greater genetic tendency for the production of IgE against
mite  than do girls and that they develop BA earlier. The 
high proportion of boys among the infants and young 
children with AD in the present study may also suggest 
that boys develop AD earlier than do girls. 
 Acquisition of mite allergy during the follow-up period 
was associated with increased prevalence of BA. In the 
present study, mite-specific IgE at registration was less 
useful for prediction than it was at re-evaluation. As the 
registered patients in our study were infants and because
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mite-specific IgE is seldom seen in infants and is more 
typically seen in atopic children at 2 years of age or 
older,9 the determination of mite-specific IgE at 
registration may be a more useful predictor in older 
children. However, in older children, it is also more likely 
that BA has already developed. 
 Food-specific IgE is a known risk factor for the later 
development of mite allergy and BA.28,35 In the present 
study, too, the patients with IgE against food developed 
mite allergy and BA more frequently than did those 
patients without IgE against food, although the difference 
was less significant. The difference between the results of 
other studies and the present study may be due to the low 
number of AD patients without food-specific IgE in the 
present study.
 A positive family history of BA, but not of AD, was 
associated with a significantly increased prevalence of 
BA, as previously described.11,33,34 This is in good 
agreement with our previous finding that children with BA 
have a high frequency of a positive family history of B.19 It 
is suggested that respiratory atopy may be controlled, at 
least in part, by factors different from those controlling 
skin atopy. 
 In general, parameters that have high sensitivity have 
low specificity and vice versa. In the present study, the 
combination of the three factors of a positive family 
history of BA, mite-specific IgE and male sex had 
satisfactory specificity and sensitivity. These parameters 
were revealed as useful risk factors for the prediction of
the development of BA within a short period in infants 
with AD. It should be examined whether or not these risk 
factors are useful in a long-term follow-up study as well. 
Among the three risk factors, male sex and a family 
history of BA are apparently genetic factors. Acquisition 
of mite-specific IgE in young children is probably also 
regulated mainly by genetic factors. Although environ-
mental risk factors are considered to play an important 
role in the recent increase in the prevalence of BA, our 
data suggest that genetic factors also play an important 
role. The genetic tendency to atopic diseases is probably 
quite apparent in children who develop both AD and BA 
early in childhood. The influence of environmental risk 
factors, such as passive smoking,15 is probably small in 
such a short follow-up period as 1 year, but it may 
become larger after a longer follow-up period. 
Environmental risk factors should also be examined and 
these studies are now in progress.
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